Abstract
In 1979, the Pediatric Division of the Southwest Oncology Group expanded greatly when almost all of the institutions whose pediatricians had participated in the activities of Cancer and Leukemia Group B joined them. In 1980, the Pediatric Division of the Southwest Oncology Group (SWOG) elected to separate from the parent organization and establish the Pediatric Oncology Group (POG). Several new institutions have joined the Group since then so that, in 1984 [1], the POG consisted of >65 participating institutions (member, affiliate, etc.) from many geographic areas of the United States as well as some areas outside of the United States. Members of the group have expertise in all modalities of therapy and broad expertise in the biologic sciences. This chapter describes some activities of the pediatric groups that joined to form the POG as well as of the Group itself. Because the Group is relatively new, many of these studies are not mature.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pediatric Oncology Group progress report 1982–1984.
Sullivan MP, Fuller LM, Chen T, et al.: Intergroup Hodgkin’s Disease in Children study of stages I and II: a preliminary report. Cancer Treat Rep 66:937–947, 1982.
Cooper MR, Pajak TF, Gottlieb AJ: et al.: The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin’s disease. J Clin Oncol 2:748–755, 1984.
Russell KJ, Donaldson SS, Cox RS, Kaplan HS: Childhood Hodgkin’s disease: patterns of relapse. J Clin Oncol 2:80, 1984.
Mauch PM, Weinstein H, Botnick L, Belli J, Cassady JR: An evaluation of long-term survival and treatment complications in children with Hodgkin’s disease. Cancer 51:925–932, 1983.
Donaldson SS: Hodgkin’s disease: treatment with low dose radiation and chemotherapy. Front Radiat Ther Oncol 16:122–133, 1982.
Bloomfield CD, Pajak TF, Glicksman AS, et al.: Chemotherapy and combined modality therapy of Hodgkin’s disease: a progress report on Cancer and Leukemia Group B studies. Cancer Treat Rep 66:835–846, 1982.
Jones SE, Coltman CA Jr, Grozea PN, De Persio EJ, Dixon DO: Conclusions from clinical trials of the Southwest Oncology Group. Cancer Treat Rep 66:847–853, 1982.
Olweny CLM, Katongole-Mbidde E, Kiire C, Lwange SK, Magrath I, Ziegler JL: Childhood Hodgkin’s disease in Uganda. Cancer 42:787–792, 1978.
Behrendt H, Van Bunningen BFM: Treatment of childhood I and II Hodgkin’s disease stages without radiotherapy. In: Cavalli F, Bonnadonna G, Rozencweig M, (eds) Malignant lymphomas and Hodgkin’s disease: Experimental and therapeutic advances. Boston: Martinus Nijhoff, 1985, pp 611–615.
Ekert H, Waters KD: Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality. Med Pideatr Oncol 11:322–326, 1983.
Bonadonna G, Zucali R, Monfardini S, et al.: Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer 36:252–259, 1975.
Santoro A, Bonadonna G, Bonfante V, Valagussa P: Alternating drug combinations in the treatment of advanced Hodgkin’s disease. N Engl J Med 306:770–775, 1982.
Da Cunha MS, Meisterich ML, Fuller LM: Recovery of spermatogenesis after treatment for Hodgkin’s disease: limiting dose of MOPP chemotherapy J Clin Oncol 2:571–577,1984.
Coltman CA Jr, Jones SE, Grozea PN, et al.: Bleomycin in combination with MOPP for the management of Hodgkin’s disease: Southwest Oncology Group experience. In: Carter SK, Crooke ST, et al.: (eds) Bleomycin: current status and new developments. Orlando FL: Academic Press, 1978, pp 227–242.
Jones SE, Haut A, Weick JK, et al.: Comparison of adriamcyin containing chemotherapy (MOP-BAP) with MOPP-bleomycin in the management of advanced Hodgkin’s disease: a Southwest Oncology Group study. Cancer 51:1339–1347, 1983.
Longo DL, Young RC, Wesley M, et al.: Twenty years of MOPP therapy for Hodgkin’s disease. J Clin Oncol 4:1295–1306, 1986.
Weiner M, Leventhal B, Falletta J, Brecher M: Treatment of advanced Hodgkin’s disease (HD) in children: a POG study. Proc Am Assoc Cancer Res 26:185, 1985.
Wagener D, Marion J, Burgers V, et al.: Sequential non-cross resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin’s disease stage HIB and IV. Cancer 52:1558–1562, 1983.
Wimmer R, Weiner M, Strauss L, et al.: Treatment of pediatric patients for relapsed Hodgkin’s disease (HD) with cytosine arabinoside (A), cisplatin (P), and etoposide (E). Proc Am Soc Cancer Oncol 6:191, 1987.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Leventhal, B.G. (1989). The Pediatric Oncology Group. In: Kamps, W.A., Humphrey, G.B., Poppema, S. (eds) Hodgkin’s Disease in Children. Cancer Treatment and Research, vol 41. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1739-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1739-5_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8978-4
Online ISBN: 978-1-4613-1739-5
eBook Packages: Springer Book Archive